Results 71 to 80 of about 31,072 (153)
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease
Isolated angiokeratomas are common benign cutaneous lesions, generally deemed unworthy of further investigation. In contrast, diffuse angiokeratomas should alert the physician to a possible diagnosis of Fabry disease, a rare X-linked lysosomal storage
the Interdisciplinary Study Group on Fabry Disease +13 more
core +2 more sources
Introduction: Gemination and fusion are rare developmental anomalies that can present significant diagnostic challenges. Due to the complexity of distinguishing between these conditions, the term “double tooth” is commonly employed in clinical practice.
Matteo Pellegrini +6 more
wiley +1 more source
Integrative Systems Biology Investigation of Fabry Disease
Fabry disease (FD) is a rare X-linked recessive genetic disorder caused by a deficient activity of the lysosomal enzyme alpha-galactosidase A (GLA) and is characterised by intra-lysosomal accumulation of globotriaosylceramide (Gb3).
Marco Fernandes, Holger Husi
doaj +1 more source
COPD is a progressive disease affecting many people worldwide. Evidence suggests that environmental factors play a vital role in the development of COPD. Proposing a nutritious diet that enhances pulmonary function could potentially be an effective approach for preventing and managing COPD.
Mohammad Vahedi Fard +3 more
wiley +1 more source
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy
Anderson-Fabry disease (AFD) is a rare genetic lysosomal storage disorder caused by deficient activity of the enzyme α-galactosidase A, leading to progressive intracellular accumulation of neutral glycosphingolipids in different organs, including the ...
Bruno, Isabella +8 more
core +1 more source
Delphi consensus on the current clinical and therapeutic knowledge on Anderson-Fabry disease.
Background: Management of Anderson–Fabry disease (AFD) is contentious, particularly regarding enzyme replacement therapy (ERT). We report results of a Delphi consensus panel on AFD management.
Concolino D. +5 more
core +2 more sources
DIAGNOSIS OF ANDERSON-FABRY DISEASE
Anderson-Fabryjeva bolest je nakon Gaucherove bolesti najčešća lizosomalna bolest nakupljanja. Bolest se nasljeđuje X-vezano recesivno. Karakterizirana je smanjenom aktivnošću enzimaIntroduction: Anderson- Fabry disease is one of the most common ...
JURAŠIĆ, MILJENKA JELENA +9 more
core
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease
Fabry disease (FD), also known as Anderson-Fabry disease, is a hereditary disorder of glycosphingolipid metabolism, caused by a deficiency of the lysosomal alpha-galactosidase A enzyme.
Oriana De Marco +19 more
doaj +1 more source
ANDERSON-FABRY DISEASE AND RENAL TRANSPLANTATION
Anderson-Fabrijeva bolest (AFB) je rijetka bolest nakupljanja koja se prenosi putem X kromosoma, a dovodi do progresivnog nakupljanja globotriaozilceramida u visceralnim organima i endotelu krvnih žila. Bolest prevenstveno zahvaća muškarce.
KAŠTELAN, ŽELJKO +11 more
core
Current therapy for Anderson–Fabry disease in Poland includes hospital or clinic-based intravenous enzyme replacement therapy with recombinant agalsidase alpha or beta, or oral pharmacological chaperone therapy with migalastat.
Stanisława Bazan-Socha +17 more
core +1 more source

